| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,592 |
15,983 |
$2.56M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
16,161 |
15,629 |
$2.04M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,949 |
4,641 |
$1.84M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
14,061 |
13,624 |
$1.14M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,139 |
2,812 |
$1.04M |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
24,346 |
12,520 |
$925K |
| 80053 |
Comprehensive metabolic panel |
16,119 |
14,091 |
$524K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
14,508 |
13,896 |
$350K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,888 |
16,858 |
$234K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,862 |
2,158 |
$234K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
969 |
912 |
$232K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,513 |
2,371 |
$232K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,747 |
1,585 |
$203K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,699 |
3,222 |
$180K |
| 87430 |
|
3,784 |
3,681 |
$135K |
| 71045 |
Radiologic examination, chest; single view |
5,521 |
5,104 |
$133K |
| 59025 |
Fetal non-stress test |
939 |
645 |
$104K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,867 |
487 |
$103K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,451 |
2,405 |
$90K |
| 87070 |
|
2,208 |
2,145 |
$86K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,163 |
1,078 |
$81K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,131 |
458 |
$74K |
| 87081 |
|
2,431 |
2,377 |
$73K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
849 |
823 |
$68K |
| 81001 |
|
7,899 |
7,002 |
$64K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,907 |
2,585 |
$62K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
408 |
390 |
$60K |
| 99001 |
|
3,068 |
2,927 |
$55K |
| 87807 |
|
1,030 |
1,010 |
$50K |
| 83880 |
|
2,126 |
1,882 |
$42K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,245 |
1,157 |
$39K |
| 84484 |
|
2,945 |
2,401 |
$28K |
| 71046 |
Radiologic examination, chest; 2 views |
1,100 |
1,064 |
$27K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
531 |
288 |
$25K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
528 |
477 |
$24K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
191 |
179 |
$24K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
316 |
261 |
$23K |
| 83690 |
|
2,635 |
2,337 |
$21K |
| 36415 |
Collection of venous blood by venipuncture |
23,099 |
17,951 |
$19K |
| CP007 |
|
549 |
490 |
$18K |
| 81025 |
|
1,393 |
1,305 |
$18K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
476 |
474 |
$16K |
| 87205 |
|
1,215 |
1,170 |
$13K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
425 |
423 |
$13K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,067 |
1,860 |
$13K |
| 81003 |
|
4,090 |
3,664 |
$13K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,408 |
1,858 |
$12K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
250 |
219 |
$12K |
| 96127 |
|
179 |
148 |
$11K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
188 |
177 |
$10K |
| 73630 |
|
303 |
266 |
$9K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,065 |
767 |
$8K |
| 87088 |
|
2,518 |
2,253 |
$8K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
185 |
31 |
$8K |
| 87077 |
|
1,680 |
1,550 |
$7K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,468 |
1,023 |
$7K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
62 |
62 |
$7K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,363 |
2,291 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,828 |
1,368 |
$7K |
| 76775 |
|
76 |
74 |
$6K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
331 |
273 |
$6K |
| 76830 |
Ultrasound, transvaginal |
48 |
46 |
$6K |
| 87210 |
|
251 |
213 |
$6K |
| 80061 |
Lipid panel |
2,407 |
2,330 |
$6K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
12 |
12 |
$5K |
| 83605 |
|
610 |
534 |
$5K |
| 87186 |
|
1,240 |
1,148 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,632 |
992 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,284 |
1,903 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,118 |
983 |
$3K |
| 84703 |
|
364 |
328 |
$3K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
40 |
40 |
$3K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
114 |
101 |
$3K |
| 73610 |
|
80 |
68 |
$3K |
| 87040 |
|
235 |
224 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,960 |
1,887 |
$3K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
22 |
22 |
$3K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
173 |
65 |
$3K |
| 90832 |
Psychotherapy, 30 minutes with patient |
102 |
83 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
629 |
611 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
742 |
625 |
$2K |
| 83735 |
|
757 |
621 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,148 |
891 |
$2K |
| 85610 |
|
1,519 |
1,184 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
60 |
57 |
$2K |
| 84702 |
|
145 |
114 |
$2K |
| 73030 |
|
72 |
62 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
46 |
31 |
$2K |
| 85379 |
|
231 |
215 |
$2K |
| 82565 |
|
802 |
764 |
$2K |
| 96376 |
|
603 |
292 |
$1K |
| 86900 |
|
435 |
390 |
$1K |
| 73562 |
|
46 |
38 |
$1K |
| 99490 |
Ccm add 20min |
533 |
532 |
$1K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
13 |
13 |
$1K |
| 87185 |
|
652 |
613 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
436 |
394 |
$994.68 |
| 82607 |
|
428 |
417 |
$971.68 |
| 80164 |
|
323 |
298 |
$933.01 |
| 80047 |
|
159 |
154 |
$906.61 |
| 85730 |
|
356 |
330 |
$817.99 |
| 93971 |
|
14 |
12 |
$780.25 |
| 72131 |
|
13 |
12 |
$777.00 |
| 86850 |
|
53 |
51 |
$744.96 |
| 84112 |
|
12 |
12 |
$731.44 |
| 73502 |
|
12 |
12 |
$673.87 |
| 86901 |
|
310 |
274 |
$506.78 |
| 85027 |
|
116 |
84 |
$505.25 |
| 90715 |
|
27 |
26 |
$441.40 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
188 |
157 |
$440.39 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
130 |
94 |
$288.62 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
94 |
38 |
$278.99 |
| 82550 |
|
15 |
12 |
$264.63 |
| 0001A |
|
185 |
183 |
$247.35 |
| 0002A |
|
98 |
96 |
$243.05 |
| 74018 |
|
16 |
12 |
$242.44 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
229 |
199 |
$239.73 |
| 97161 |
|
13 |
12 |
$210.07 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
14 |
$207.91 |
| 82728 |
|
161 |
157 |
$203.35 |
| 80320 |
|
13 |
12 |
$177.46 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
41 |
28 |
$151.62 |
| 84439 |
|
184 |
176 |
$134.79 |
| 83540 |
|
183 |
175 |
$107.80 |
| 82570 |
|
173 |
164 |
$104.42 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
35 |
24 |
$74.64 |
| 99406 |
|
15 |
13 |
$73.77 |
| 82043 |
|
110 |
109 |
$55.92 |
| 83550 |
|
79 |
76 |
$55.69 |
| 80069 |
|
54 |
51 |
$52.62 |
| 82746 |
|
53 |
52 |
$44.27 |
| 81002 |
|
17 |
13 |
$44.07 |
| 84100 |
|
16 |
13 |
$35.53 |
| 85651 |
|
34 |
26 |
$33.54 |
| 99173 |
|
15 |
12 |
$32.04 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
31 |
25 |
$29.11 |
| 92558 |
|
15 |
12 |
$28.50 |
| 82962 |
|
1,470 |
891 |
$6.69 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
12 |
12 |
$0.76 |
| J2704 |
Injection, propofol, 10 mg |
344 |
309 |
$0.00 |
| 0012A |
|
22 |
22 |
$0.00 |
| 0011A |
|
25 |
25 |
$0.00 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
137 |
116 |
$0.00 |
| 90863 |
|
32 |
26 |
$0.00 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
22 |
22 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15 |
12 |
$0.00 |